Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Operating Leases (2019 - 2025)

Marimed (MRMD) has disclosed Operating Leases for 7 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 12.36% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, down 12.36% year-over-year, with the annual reading at $6.6 million for FY2025, 12.36% down from the prior year.
  • Operating Leases for Q4 2025 was $6.6 million at Marimed, down from $6.8 million in the prior quarter.
  • The five-year high for Operating Leases was $10.5 million in Q2 2023, with the low at $4.2 million in Q4 2022.
  • Average Operating Leases over 5 years is $7.0 million, with a median of $7.1 million recorded in 2025.
  • The sharpest move saw Operating Leases skyrocketed 144.76% in 2023, then fell 29.98% in 2025.
  • Over 5 years, Operating Leases stood at $4.6 million in 2021, then dropped by 8.77% to $4.2 million in 2022, then skyrocketed by 102.61% to $8.5 million in 2023, then dropped by 10.72% to $7.5 million in 2024, then fell by 12.36% to $6.6 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $6.6 million, $6.8 million, and $9.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.